| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
*
Department of Pathology, University of Texas Southwestern Medical Center, Dallas, TX 75235;
Laboratory of Experimental Immunology, Division of Basic Sciences, National Cancer Institute, Frederick Cancer Research and Development Center, Frederick, MD 21702; and
Human Health Research Center, Institut National de la Reserche Scientifique-Institute Armand-Frappier, University of Quebec, Laval, Canada
Class I-specific stimulatory and inhibitory receptors expressed by NK cell subsets contribute to the alloreactive potential of the self-tolerant murine NK cell repertoire. In this report, we have studied potential mechanisms of tolerance to the function of the positive signaling Ly49D receptor in mice that express one of its ligands, H2-Dd. Our results demonstrate that H2-Dd-expressing mice possess a large Ly49D+ subset of NK cells that is functionally capable of rejecting bone marrow cell (BMC) allografts in vivo and lysing allogeneic Con A lymphoblasts in vitro. Also, we show that the Ly49D receptor is responsible for the ability of H2b/d F1 hybrid mice to reject H2d/d parental BMC (hybrid resistance). Thus, deletion or anergy of Ly49D+ cells in H2-Dd+ hosts cannot explain self tolerance. Our functional studies revealed that coexpression of the Dd-specific Ly49A or Ly49G2 inhibitory receptors by Ly49D+ cells resulted in tolerance to Dd+ targets, while coexpression of Kb-specific inhibitory receptors Ly49C/I resulted in tolerance to Kb+ targets. Only in H2d/d cells did Ly49C/I dominantly inhibit Ly49D-Dd stimulation. This correlated with an increased mean fluorescence intensity of Ly49C expression, as well as an increased percentage of Ly49C+ cells in the Ly49D+A/G2- compartment. Therefore, we conclude that self tolerance of the Ly49D subset can be achieved through coexpression of a sufficient level of self-specific inhibitory receptors.
This article has been cited by other articles:
|
|
 |
|
  J. D. French, C. L. Roark, W. K. Born, and R. L. O'Brien {gamma}{delta} T Lymphocyte Homeostasis Is Negatively Regulated by {beta}2-Microglobulin J. Immunol., February 15, 2009; 182(4): 1892 - 1900. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. Merck, R. B. Voyle, and H. R. MacDonald Ly49D Engagement on T Lymphocytes Induces TCR-Independent Activation and CD8 Effector Functions That Control Tumor Growth J. Immunol., January 1, 2009; 182(1): 183 - 192. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. K. Tripathy, P. A. Keyel, L. Yang, J. T. Pingel, T. P. Cheng, A. Schneeberger, and W. M. Yokoyama Continuous engagement of a self-specific activation receptor induces NK cell tolerance J. Exp. Med., August 4, 2008; 205(8): 1829 - 1841. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. C. Sun and L. L. Lanier Tolerance of NK cells encountering their viral ligand during development J. Exp. Med., August 4, 2008; 205(8): 1819 - 1828. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. H. Chewning, C. N. Gudme, K. C. Hsu, A. Selvakumar, and B. Dupont KIR2DS1-Positive NK Cells Mediate Alloresponse against the C2 HLA-KIR Ligand Group In Vitro J. Immunol., July 15, 2007; 179(2): 854 - 868. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y. Huang, F. Rezzoug, H. Xu, P. M. Chilton, C. L. Schanie, I. Fugier-Vivier, and S. T. Ildstad NK Cells Play a Critical Role in the Regulation of Class I-Deficient Hemopoietic Stem Cell Engraftment: Evidence for NK Tolerance Correlates with Receptor Editing J. Immunol., September 15, 2005; 175(6): 3753 - 3761. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. Westerhuis, W. G. E. Maas, R. Willemze, R. E. M. Toes, and W. E. Fibbe Long-term mixed chimerism after immunologic conditioning and MHC-mismatched stem-cell transplantation is dependent on NK-cell tolerance Blood, September 15, 2005; 106(6): 2215 - 2220. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Naper, K.-Z. Dai, L. Kveberg, B. Rolstad, E. C. Niemi, J. T. Vaage, and J. C. Ryan Two Structurally Related Rat Ly49 Receptors with Opposing Functions (Ly49 Stimulatory Receptor 5 and Ly49 Inhibitory Receptor 5) Recognize Nonclassical MHC Class Ib-Encoded Target Ligands J. Immunol., March 1, 2005; 174(5): 2702 - 2711. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Regunathan, Y. Chen, D. Wang, and S. Malarkannan NKG2D receptor-mediated NK cell function is regulated by inhibitory Ly49 receptors Blood, January 1, 2005; 105(1): 233 - 240. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. M. Mooney, J. Klem, C. Wulfing, L. A. Mijares, P. L. Schwartzberg, M. Bennett, and J. D. Schatzle The Murine NK Receptor 2B4 (CD244) Exhibits Inhibitory Function Independent of Signaling Lymphocytic Activation Molecule-Associated Protein Expression J. Immunol., September 15, 2004; 173(6): 3953 - 3961. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K.-M. Lee, M. E. McNerney, S. E. Stepp, P. A. Mathew, J. D. Schatzle, M. Bennett, and V. Kumar 2B4 Acts As a Non-Major Histocompatibility Complex Binding Inhibitory Receptor on Mouse Natural Killer Cells J. Exp. Med., May 3, 2004; 199(9): 1245 - 1254. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Y. Koh, J. R. Ortaldo, B. R. Blazar, M. Bennett, and W. J. Murphy NK-cell purging of leukemia: superior antitumor effects of NK cells H2 allogeneic to the tumor and augmentation with inhibitory receptor blockade Blood, December 1, 2003; 102(12): 4067 - 4075. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. J. Ma, E. T. Silver, B. Hazes, and K. P. Kane Reciprocal Transfer of Class I MHC Allele Specificity between Activating Ly-49P and Ly-49W Receptors by Exchange of {beta}4-{beta}5 Loop Residues J. Immunol., November 15, 2003; 171(10): 5337 - 5344. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Pearson, T. G. Markees, D. V. Serreze, M. A. Pierce, M. P. Marron, L. S. Wicker, L. B. Peterson, L. D. Shultz, J. P. Mordes, A. A. Rossini, et al. Genetic Disassociation of Autoimmunity and Resistance to Costimulation Blockade-Induced Transplantation Tolerance in Nonobese Diabetic Mice J. Immunol., July 1, 2003; 171(1): 185 - 195. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y. Zhao, H. Ohdan, J. O. Manilay, and M. Sykes NK Cell Tolerance in Mixed Allogeneic Chimeras J. Immunol., June 1, 2003; 170(11): 5398 - 5405. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. T. Silver, K. J. Lavender, D.-E. Gong, B. Hazes, and K. P. Kane Allelic Variation in the Ectodomain of the Inhibitory Ly-49G2 Receptor Alters Its Specificity for Allogeneic and Xenogeneic Ligands J. Immunol., November 1, 2002; 169(9): 4752 - 4760. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. A. Morris, J. Liu, V. Arora, T. C. George, J. Klem, J. D. Schatzle, V. Kumar, and M. Bennett B6 Strain Ly49I Inhibitory Gene Expression on T Cells in FVB.Ly49IB6 Transgenic Mice Fails to Prevent Normal T Cell Functions J. Immunol., October 1, 2002; 169(7): 3661 - 3666. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Raziuddin, D. L. Longo, M. Bennett, R. Winkler-Pickett, J. R. Ortaldo, and W. J. Murphy Increased bone marrow allograft rejection by depletion of NK cells expressing inhibitory Ly49 NK receptors for donor class I antigens Blood, September 26, 2002; 100(8): 3026 - 3033. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Naper, S. Hayashi, L. Kveberg, E. C. Niemi, L. L. Lanier, J. T. Vaage, and J. C. Ryan Ly-49s3 Is a Promiscuous Activating Rat NK Cell Receptor for Nonclassical MHC Class I-Encoded Target Ligands J. Immunol., July 1, 2002; 169(1): 22 - 30. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. Furukawa, K. Iizuka, J. Poursine-Laurent, N. Shastri, and W. M. Yokoyama A Ligand for the Murine NK Activation Receptor Ly-49D: Activation of Tolerized NK Cells from {beta}2-Microglobulin- Deficient Mice J. Immunol., July 1, 2002; 169(1): 126 - 136. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. Forman, R. M. Welsh, T. G. Markees, B. A. Woda, J. P. Mordes, A. A. Rossini, and D. L. Greiner Viral Abrogation of Stem Cell Transplantation Tolerance Causes Graft Rejection and Host Death by Different Mechanisms J. Immunol., June 15, 2002; 168(12): 6047 - 6056. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Y. Koh, B. R. Blazar, T. George, L. A. Welniak, C. M. Capitini, A. Raziuddin, W. J. Murphy, and M. Bennett Augmentation of antitumor effects by NK cell inhibitory receptor blockade in vitro and in vivo Blood, May 15, 2001; 97(10): 3132 - 3137. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. R. Ortaldo, E. W. Bere, D. Hodge, and H. A. Young Activating Ly-49 NK Receptors: Central Role in Cytokine and Chemokine Production J. Immunol., April 15, 2001; 166(8): 4994 - 4999. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. Toyama-Sorimachi, Y. Taguchi, H. Yagita, F. Kitamura, A. Kawasaki, S. Koyasu, and H. Karasuyama Mouse CD94 Participates in Qa-1-Mediated Self Recognition by NK Cells and Delivers Inhibitory Signals Independent of Ly-49 J. Immunol., March 15, 2001; 166(6): 3771 - 3779. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. T. Silver, D.-E. Gong, B. Hazes, and K. P. Kane Ly-49W, an Activating Receptor of Nonobese Diabetic Mice With Close Homology to the Inhibitory Receptor Ly-49G, Recognizes H-2Dk and H-2Dd J. Immunol., February 15, 2001; 166(4): 2333 - 2341. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. R. Ortaldo, R. Winkler-Pickett, and G. Wiegand Activating Ly-49D NK receptors: expression and function in relation to ontogeny and Ly-49 inhibitor receptors J. Leukoc. Biol., November 1, 2000; 68(5): 748 - 756. [Abstract] [Full Text]
|
|
|
|
|
|
E. T. Silver, D.-E. Gong, C. S. Chang, A. Amrani, P. Santamaria, and K. P. Kane Ly-49P Activates NK-Mediated Lysis by Recognizing H-2Dd 1 J. Immunol., August 15, 2000; 165(4): 1771 - 1781. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
